Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Toxicology and Applied Pharmacology|September 21, 2010
Enzyme sequence similarity improves the reaction alignment method for cross-species pathway comparisonMeric A Ovacik, Ioannis P Androulakis
The Journal of Pharmacology and Experimental Therapeutics|July 12, 2015
Logic-Based and Cellular Pharmacodynamic Modeling of Bortezomib Responses in U266 Human Myeloma CellsVaishali L Chudasama, Meric A Ovacik, Darrell R Abernethy, et al.
Toxicology and Applied Pharmacology|July 28, 2010
Transcriptional and metabolic flux profiling of triadimefon effects on cultured hepatocytesVidya V Iyer, Meric A Ovacik, Ioannis P Androulakis, et al.
Toxicology and Applied Pharmacology|September 21, 2010
Pathway modeling of microarray data: a case study of pathway activity changes in the testis following in utero exposure to dibutyl phthalate (DBP)Meric A Ovacik, Banalata Sen, Susan Y Euling, et al.
BMC Bioinformatics|November 3, 2010
Circadian signatures in rat liver: from gene expression to pathwaysMeric A Ovacik, Siddharth Sukumaran, Richard R Almon, et al.
The AAPS Journal|September 20, 2022
Nonclinical Pharmacokinetics, Pharmacodynamics, and Translational Model of RO7297089, A Novel Anti-BCMA/CD16A Bispecific Tetravalent Antibody for the Treatment of Multiple MyelomaHao Cai, Satoko Kakiuchi-Kiyota, Robert Hendricks, et al.
The AAPS Journal|January 3, 2024
A Bispecific Modeling Framework Enables the Prediction of Efficacy, Toxicity, and Optimal Molecular Design of Bispecific Antibodies Targeting MerTKRan Li, Edward Dere, Mandy Kwong, et al.
Toxicology and Applied Pharmacology|July 13, 2011
Use of genomic data in risk assessment case study: II. Evaluation of the dibutyl phthalate toxicogenomic data setSusan Y Euling, Lori D White, Andrea S Kim, et al.
Mabs|December 9, 2016
Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cellsMichael Dillon, Yiyuan Yin, Jianhui Zhou, et al.
Pharmaceutics|May 28, 2022
Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell MalignanciesRajbharan Yadav, Siddharth Sukumaran, Tanja S Zabka, et al.
Pageof 1